A prospective study of concurrent cyclophosphamide/methotrexate/5-flourouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma

J. R. Bellon, L. N. Shulman, S. E. Come, X. Li, R. S. Gelman, B. J. Silver, J. R. Harris, A. Recht, Amit K. Garg, Thomas A. Buchholz

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)143-144
Number of pages2
JournalWomen's Oncology Review
Volume4
Issue number2
DOIs
StatePublished - Jun 1 2004
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology
  • Cancer Research

Cite this

Bellon, J. R., Shulman, L. N., Come, S. E., Li, X., Gelman, R. S., Silver, B. J., Harris, J. R., Recht, A., Garg, A. K., & Buchholz, T. A. (2004). A prospective study of concurrent cyclophosphamide/methotrexate/5-flourouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Women's Oncology Review, 4(2), 143-144. https://doi.org/10.1080/1473340410001732406